Conflicts of interest in dialysis: A barrier to policy reforms

Aaron Glickman1, Eugene Lin2,3,4, Jeffrey S Berns5

  • 1Department of Medical Ethics & Health Policy, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

Seminars in Dialysis
|January 4, 2020
PubMed

Insights

Physician conflicts of interest are common, especially in nephrology through dialysis joint ventures (JVs) and End-stage Kidney Disease Seamless Care Organizations (ESCOs). Their impact on patient care remains unknown due to limited data.

Area of Science:

  • Medical Ethics
  • Nephrology
  • Healthcare Management

Background:

  • Physician conflicts of interest (COI) are prevalent across medical specialties in the US.
  • In nephrology, COI frequently arise from dialysis facility joint ventures (JVs) and financial involvement in End-stage Kidney Disease Seamless Care Organizations (ESCOs).

Purpose of the Study:

  • To explore the potential benefits and risks associated with nephrologists' financial participation in JVs and ESCOs.
  • To examine the current lack of transparency and independent research opportunities regarding COI in nephrology settings.
  • To discuss potential mechanisms for disclosing and reporting these financial arrangements and mitigating associated risks.

Main Methods:

  • This study involves a discussion and analysis of existing literature and potential implications.
  • It does not present new empirical data but rather synthesizes information on financial arrangements and their ethical considerations.
  • The approach includes examining the landscape of nephrologist financial involvements and proposing frameworks for oversight.

Main Results:

  • The direct impact of these financial arrangements on clinical decision-making and patient outcomes in nephrology is currently unknown.
  • There is a noted lack of transparent, publicly accessible information, hindering independent research.
  • Potential benefits and risks for nephrologists involved in JVs and ESCOs are discussed.

Conclusions:

  • Understanding and addressing conflicts of interest in nephrology is crucial for maintaining patient trust and ensuring high-quality care.
  • Establishing clear disclosure, reporting, and risk mitigation strategies for nephrologist financial involvements in JVs and ESCOs is recommended.
  • Further research is needed to elucidate the precise effects of these financial relationships on patient care.

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
499
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.1K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.5K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.1K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
631
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
411